©istock.com/Andrea Obzerova
Interdisziplinäre KompetenzMolekulare Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patienten.

ErkrankungGM1-Gangliosidose Typ III, Differentialdiagnose

Zusammenfassung

Kurzinformation

Umfassendes differentialdiagnostisches panel für GM1-Gangliosidose Typ III mit 26 kuratierten Genen gemäß klinischer Verdachtsdiagnose

ID
GP0919
Anzahl Gene
26 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
2,1 kb (Core-/Basis-Gene)
59,4 kb (Erweitertes Panel)
Analyse-Dauer
auf Anfrage
Material
  • EDTA-Blut (3-5 ml)

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GErbgang
GLB12034AR
AR2763XLR und/oder SMu
ATP7B4398AR
C9orf721446AD
CHCHD10429AD
CLN6936AR
CTSF1455AR
DNAJC5597AD
DNAJC62913AR
FBXO71332AR
FUS1581AD und/oder AR und/oder Gen Fusion
FXN633AR und/oder Ass
GALNS1569AR
HEXA1590AR
HEXB1671AR
HTT9429AD
PARK7570AR und/oder Dig
PINK11746AR und/oder Dig und/oder Sus
PRKN1398AD und/oder SMu und/oder Sus
SMN1885AR
SOD1465AD und/oder AR
SYNJ14839AR
TARDBP1245AD
TFG1203AD und/oder AR
VAPB732AD
VPS13C11512AR

Infos zur Erkrankung

Synonyme
  • Alias: Beta-galactosidase-1 deficiency
  • Alias: Infantile GM1 gangliosidosis
  • Alias: Landing disease, Norman-Landing disease
  • Allelic: Hypospadias 1, XL (AR)
  • Allelic: Lopes-Maciel-Rodan syndrome (HTT)
  • Allelic: Myopathy, isolated mitochondrial, AD (CHCHD10)
  • Allelic: Spinal muscular atrophy, Jokela type (CHCHD10
  • Amyotrophic lateral sclerosis 10, with/-out FTD (TARDBP)
  • Amyotrophic lateral sclerosis 6, with/-out frontotemporal dementia (FUS)
  • Amyotrophic lateral sclerosis 8 (VAPB)
  • Androgen insensitivity (AR)
  • Androgen insensitivity, partial (AR)
  • Ceroid lipofuscinosis, neuronal, 13, Kufs type, AD (CTSF)
  • Ceroid lipofuscinosis, neuronal, 4A, Kufs type, (CLN6)
  • Ceroid lipofuscinosis, neuronal, 4B, Kufs type, AD (DNAJC5)
  • Ceroid lipofuscinosis, neuronal, 6 (CLN6)
  • Essential tremor, hereditary, 4 (FUS)
  • Friedreich ataxia (FXN)
  • Friedreich ataxia with retained reflexes (FXN)
  • Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 (C9orf72)
  • Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (CHCHD10)
  • Frontotemporal lobar degeneration, TARDBP-related (TARDBP)
  • GM1-gangliosidosis, type I (GLB1)
  • GM1-gangliosidosis, type II (GLB1)
  • GM1-gangliosidosis, type III (GLB1)
  • GM2-gangliosidosis, several forms (HEXA)
  • Hereditary motor and sensory neuropathy, Okinawa type (TFG)
  • Hex A pseudodeficiency (HEXA)
  • Huntington disease (HTT_CAG)
  • Mucopolysaccharidosis IVA (GALNS)
  • Mucopolysaccharidosis type IVB, Morquio (GLB1)
  • Parkinson disease 15, AR (FBXO7)
  • Parkinson disease 19a, juvenile-onset (DNAJC6)
  • Parkinson disease 19b, early-onset (DNAJC6)
  • Parkinson disease 23, AR, early onset (VPS13C)
  • Parkinson disease 6, early onset (PINK1)
  • Parkinson disease 7, AR early-onset (PARK7)
  • Parkinson disease, juvenile, type 2 (PRKN)
  • Sandhoff disease, infantile, juvenile + adult forms (HEXB)
  • Spastic paraplegia 57, AR (TFG)
  • Spinal and bulbar muscular atrophy of Kennedy (AR_CAG)
  • Spinal muscular atrophy, late-onset, Finkel type (VAPB)
  • Spinal muscular atrophy-1-4 (SMN1)
  • Tay-Sachs disease (HEXA)
  • Wilson disease (ATP7B)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AD und/oder AR
  • AD und/oder AR und/oder Gen Fusion
  • AD und/oder SMu und/oder Sus
  • AR
  • AR und/oder Ass
  • AR und/oder Dig
  • AR und/oder Dig und/oder Sus
  • XLR und/oder SMu
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code
E75.1

Bioinformatik und klinische Interpretation

Kein Text hinterlegt